Compare HWKN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HWKN | STVN |
|---|---|---|
| Founded | 1938 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 1995 | 2021 |
| Metric | HWKN | STVN |
|---|---|---|
| Price | $156.08 | $18.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $200.00 | $25.67 |
| AVG Volume (30 Days) | 111.4K | ★ 360.2K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.46% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.91 | N/A |
| Revenue | ★ $1,083,696,000.00 | N/A |
| Revenue This Year | $12.37 | $9.67 |
| Revenue Next Year | $6.30 | $9.99 |
| P/E Ratio | $40.81 | ★ $27.15 |
| Revenue Growth | ★ 11.21 | N/A |
| 52 Week Low | $117.98 | $12.89 |
| 52 Week High | $186.15 | $28.00 |
| Indicator | HWKN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 67.27 |
| Support Level | $143.46 | $17.23 |
| Resistance Level | $174.01 | $19.05 |
| Average True Range (ATR) | 7.61 | 0.65 |
| MACD | -0.76 | -0.03 |
| Stochastic Oscillator | 37.81 | 70.81 |
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.